We can't find the internet
Attempting to reconnect
29588.1 IP-LS
29588.1 IP-LS
Résumé
Mechanistic insights into the effects of TOP-N53 in diabetic models.
Textes supplémentaires
Abstract
Diabetic foot ulcer (DFU) is a serious complication of diabetes mellitus. We aim to study mechanistic effects of sustained and acute-release formulations of our drug candidate, TOP-N53, in diabetic models. This innovative candidate will enable significant improvements in patients# quality of life.
Participants
Paola Atzei
Wirtschaftspartner
paola.atzei@topadur.com
Topadur Pharma AG CHE-481.951.668 Paola Atzei Grabenstrasse 11a 8952 Schlieren ZH CH
Sabine Werner
Kontaktperson
sabine.werner@biol.ethz.ch
ETH Zürich Sabine Werner Otto-Stern-weg 7 8093 Zürich ZH CH
Détails du projet
- Office de recherche
- INNOSUISSE
- Statut du projet
- Abgeschlossen
- Type de projet
- Forschungsprojekt
- Date de début
- 2018-10-31
- Date de fin
- 2022-10-31
- Coûts totaux approuvés
- CHF 1176953.09
- Section
- 60 Life Sciences
- Domaine politique NABS
- Industrielle Produktivität und Technologie
Disciplines de recherche
- T410 Pharmaceuticals and related technologies 100.0%